Drug Shortage Report for DAPTOMYCIN FOR INJECTION

Last updated on 2023-06-28 History
Report ID 193379
Drug Identification Number 02490838
Brand name DAPTOMYCIN FOR INJECTION
Common or Proper name DAPTOMYCIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) DAPTOMYCIN
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size LYVI
ATC code J01XX
ATC description OTHER ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-05-30
Estimated end date 2023-06-23
Actual end date 2023-06-27
Shortage status Resolved
Updated date 2023-06-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2023-06-28 English Compare
v10 2023-06-27 French Compare
v9 2023-06-27 English Compare
v8 2023-06-12 French Compare
v7 2023-06-12 English Compare
v6 2023-06-05 French Compare
v5 2023-06-05 English Compare
v4 2023-05-31 English Compare
v3 2023-05-30 French Compare
v2 2023-05-30 English Compare
v1 2023-05-30 English Compare

Showing 1 to 11 of 11